XK
EDIT icon

Xact Kapitalforvaltning’s Editas Medicine EDIT Stock Holding History

Xact Kapitalforvaltning’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$345K Hold
17,400
– – 0.01% 925
2019
Q4 		$515K Buy
+17,400
New +$435K 0.01% 946
2018
Q4 		– Sell
-6,300
Closed -$200K – 1503
2018
Q3 		$200K Hold
6,300
– – ﹤0.01% 1521
2018
Q2 		$226K Buy
+6,300
New +$223K ﹤0.01% 1503

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Xact Kapitalforvaltning's EDIT Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Editas Medicine (EDIT) position steady in Q1 2020 at 17,400 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #925.

Xact Kapitalforvaltning first reported a position in EDIT in Q2 2018 and has held it in 4 quarters since. The position peaked at $515K in Q4 2019. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.

  • Xact Kapitalforvaltning held 17,400 shares of Editas Medicine worth $345K as of Q1 2020.
  • Xact Kapitalforvaltning left its Editas Medicine share count unchanged in Q1 2020.
  • Editas Medicine made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #925 holding.
  • Xact Kapitalforvaltning first reported a position in Editas Medicine in Q2 2018 and has held it in 4 quarters since.
  • Xact Kapitalforvaltning's Editas Medicine position peaked at $515K in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.